Novartis is not so thrilled with recent India treatment of IP. A company spokesman, Novartis India Vice Chairman and Managing Director Ranjit Shahani, said, "The recent cases that we have seen in the area of IPR do not in any way point to an environment that encourages innovation. A patent is granted then revoked. A patent is granted then violated. A patent is granted then a compulsory license is issued."
Tell us what you really think Ranjit. "What we certainly would like to see is an ecosystem that fosters innovation and fast-track courts to hear and decide cases involving IPR. China has drawn all the leading global companies to invest in R&D there while India has not. That itself should serve as food for thought," he said.
Shahani said the government needs to have a holistic approach and look at global companies as being part of the solution. See Economic Times.
Posted by Bruce Lehr Aug 19th 2013.